The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Virginia Republicans, facing a one-seat minority, hope to tackle the fentanyl crisis with stringent punishments including ...

Clinical trials are underway in Colorado for a new drug that could extend a dog's lifespan. Loyal, a San Francisco based ...

The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Washington state tries new way to ...

An increasing number of overdose deaths in Ontario involves the use of more than one drug, with the combination of opioids ...

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...